Addressing challenges in the diagnosis and treatment of rare genetic diseases

Article metrics


The past 5 years have seen an unprecedented rate of discovery of genes that cause rare diseases and with it a commensurate increase in the number of diagnosable but nevertheless untreatable disorders. Here, we discuss the increasing opportunity for diagnosis and therapy of rare diseases and how to tackle the associated challenges.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Boycott, K. M. et al. International cooperation to enable the diagnosis of all rare genetic diseases. Am. J. Hum. Genet. 10, 695–705 (2017).

  2. 2

    Giannuzzi, V. et al. Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen. Orphanet J. Rare Dis. 12, 64–75 (2017).

  3. 3

    Dawkins, H. J. S. et al. Progress in rare diseases research 2010-2016: an IRDiRC perspective. Clin. Transl Sci. (2017).

  4. 4

    Meekings, K. N., Williams, C. S. & Arrowsmith, J. E. Orphan drug development: an economically viable strategy for biopharma R&D. Drug Disc. Today 17, 660–664 (2012).

  5. 5

    Austin, C. P. et al. Future of rare diseases research 2017–2027: an IRDiRC perspective. Clin. Transl Sci. (2017).

Download references


The authors would like to thank A. MacKenzie for helpful discussions, and H. Howley and T. Hartley for editing the manuscript.

Author information

Correspondence to Kym M. Boycott.

Ethics declarations

Competing interests

K.M.B. declares no competing interests. D.A. is a full-time employee of Chiesi Farmaceutici S.p.A.

Related links

Related links


European Reference Networks



Matchmaker Exchange

Online Mendelian Inheritance in Man


Rare Disease Clinical Research Network

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Boycott, K., Ardigó, D. Addressing challenges in the diagnosis and treatment of rare genetic diseases. Nat Rev Drug Discov 17, 151–152 (2018) doi:10.1038/nrd.2017.246

Download citation

Further reading